First Line Ovarian Cancer Treatment - Cohort Study
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The French cooperative group GINECO proposes to implement an observational study to describe
a real situation, in daily practice tolerance and methods of administration of bevacizumab
(Avastin ®)